证券代码：603079 证券简称：圣达生物 公告编号：2025-058 浙江圣达生物药业股份有限公司 2025年第三季度主要经营数据公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第3号行业信息披露：第十三 号——化工》及《上市公司自律监管指引第3号行业信息披露：第十四号——食 品制造》的要求，现将浙江圣达生物药业股份有限公司（以下简称"公司"） 2025年第三季度主要经营数据披露如下： 注：公司主要产品中，维生素产品包括生物素（折纯）、叶酸（折纯）；生物保鲜剂 及功能配料产品包括乳酸链球菌素、纳他霉素、聚赖氨酸和蔗糖发酵物等。 生物素（折纯）产量包含公司外购生物素粗品精制加工的生物素纯品。 二、报告期内主要产品销售地区分布基本情况 三、报告期内主要产品和原材料的价格变动情况 比下降17.06%；生物保鲜剂及功能配料平均销售价格较上年同期下降0.76%，环 比下降5.82%。 2、主要原材料价格（不含税）变动情况 第三季度，公司主要原材料三氨基盐平均采购价格较上年同期下降 23.3 ...

Core Viewpoint - The company, Zhejiang Shengda Biological Pharmaceutical Co., Ltd., is undergoing a change in its auditing firm for the 2025 fiscal year, transitioning from Tianjian Accounting Firm to RSM China (致同会计师事务所) due to the need for fresh auditing perspectives and compliance with regulations [4][11]. Group 1: Company Overview - The company is identified by the stock code 603079 and is referred to as Shengda Biological [3]. - The company has confirmed that there are no changes in its controlling shareholders or actual controllers during the reporting period [2]. Group 2: Financial Data - The company raised a total of RMB 267.61 million through a stock issuance, with a net amount of RMB 261.42 million after deducting issuance costs [48]. - The average selling price of the company's main products, vitamins, increased by 45.78% year-on-year and 4.98% quarter-on-quarter in the second quarter [57]. Group 3: Audit Firm Change - The new auditing firm, RSM China, has been selected based on its professional competence and experience in providing auditing services to listed companies [11][12]. - The previous auditing firm, Tianjian, provided standard unqualified opinions for the 2024 financial report [11]. - The change in auditing firms was communicated to both the outgoing and incoming firms, with no objections raised [4][11]. Group 4: Shareholder Meeting - The third extraordinary general meeting of shareholders is scheduled for September 10, 2025, to discuss the appointment of the new auditing firm [15][14]. - The voting for the shareholder meeting will be conducted through both on-site and online methods [15][16]. Group 5: Fund Management - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and managed according to regulatory requirements [50][51]. - There were no instances of using idle raised funds for temporary working capital during the reporting period [55].